{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:15Z","timestamp":1790484315326,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,27]]},"DOI":"10.1097\/tp.0b013e318176b40f","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:46:21Z","timestamp":1236267981000},"page":"231-237","source":"Crossref","is-referenced-by-count":62,"title":["Bisphosphonates and Bone Fractures in Long-term Kidney Transplant Recipients"],"prefix":"10.1097","volume":"86","author":[{"given":"Emily","family":"Conley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Muth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Armbrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210211","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01510506","article-title":"Bone disease after renal transplantation.","volume":"1","author":"Weisinger","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-10-20210211","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","article-title":"Management of bone loss after organ transplantation.","volume":"19","author":"Cohen","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R3-10-20210211","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1681\/ASN.2006050427","article-title":"Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression.","volume":"18","author":"Cunningham","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R4-10-20210211","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.TP.0000149698.79739.EF","article-title":"Posttransplantation bone disease.","volume":"79","author":"Cunningham","year":"2005","journal-title":"Transplantation"},{"key":"R5-10-20210211","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate.","volume":"76","author":"Jeffery","year":"2003","journal-title":"Transplantation"},{"key":"R6-10-20210211","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/ndt\/gfl104","article-title":"Effects of bisphosphonates on bone loss in the first year after renal transplantation\u2014A meta-analysis of randomized controlled trials.","volume":"21","author":"Mitterbauer","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R7-10-20210211","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2004-1978","article-title":"Osteoporosis after solid organ transplantation.","volume":"90","author":"Maalouf","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-10-20210211","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/00007890-199410270-00009","article-title":"Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients.","volume":"58","author":"Grotz","year":"1994","journal-title":"Transplantation"},{"key":"R9-10-20210211","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ndt\/gfm217","article-title":"Bisphosphonates in the renal patient.","volume":"22","author":"Cunningham","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R10-10-20210211","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-6143.2002.020111.x","article-title":"Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate.","volume":"2","author":"Cruz","year":"2002","journal-title":"Am J Transplant"},{"key":"R11-10-20210211","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate.","volume":"14","author":"Coco","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R12-10-20210211","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00198-007-0361-9","article-title":"Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.","volume":"18","author":"Pascual","year":"2007","journal-title":"Osteoporos Int"},{"key":"R13-10-20210211","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1345\/aph.1E589","article-title":"Zoledronic acid and renal toxicity: Data from French adverse effect reporting database.","volume":"39","author":"Munier","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R14-10-20210211","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1056\/NEJMp068157","article-title":"Osteonecrosis of the jaw\u2014Do bisphosphonates pose a risk?","volume":"355","author":"Bilezikian","year":"2006","journal-title":"N Engl J Med"},{"key":"R15-10-20210211","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1023\/A:1016495221567","article-title":"What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.","volume":"47","author":"Graham","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R16-10-20210211","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00002018-200730090-00003","article-title":"Safety considerations with bisphosphonates for the treatment of osteoporosis.","volume":"30","author":"Strampel","year":"2007","journal-title":"Drug Saf"},{"key":"R17-10-20210211","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"R18-10-20210211","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"R19-10-20210211","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00007890-199810270-00007","article-title":"Treatment of osteopenia and osteoporosis after kidney transplantation.","volume":"66","author":"Grotz","year":"1998","journal-title":"Transplantation"},{"key":"R20-10-20210211","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1359\/jbmr.2001.16.11.2111","article-title":"Alendronate prevents further bone loss in renal transplant recipients.","volume":"16","author":"Giannini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R21-10-20210211","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1046\/j.1523-1755.2003.00270.x","article-title":"Disease progression and outcomes in chronic kidney disease and renal transplantation.","volume":"64","author":"Djamali","year":"2003","journal-title":"Kidney Int"},{"key":"R22-10-20210211","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ndt\/gfm590","article-title":"CKD stage-to-stage progression in native and transplant kidney disease.","volume":"23","author":"Kukla","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R23-10-20210211","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00007890-200208270-00011","article-title":"Bone mineral density and fracture prevalence in long-term kidney graft recipients.","volume":"74","author":"Durieux","year":"2002","journal-title":"Transplantation"},{"key":"R24-10-20210211","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00007890-200208150-00012","article-title":"Risk factors for fractures in kidney transplantation.","volume":"74","author":"O\u2019Shaughnessy","year":"2002","journal-title":"Transplantation"},{"key":"R25-10-20210211","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00198-003-1532-y","article-title":"Long-term fracture risk following renal transplantation: A population-based study.","volume":"15","author":"Vautour","year":"2004","journal-title":"Osteoporos Int"},{"key":"R26-10-20210211","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1210\/en.2007-0215","article-title":"Overexpression of gamma- glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis.","volume":"148","author":"Hiramatsu","year":"2007","journal-title":"Endocrinology"},{"key":"R27-10-20210211","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1074\/jbc.M311905200","article-title":"Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.","volume":"279","author":"Niida","year":"2004","journal-title":"J Biol Chem"},{"key":"R28-10-20210211","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bone.2006.06.029","article-title":"Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.","volume":"39","author":"Asaba","year":"2006","journal-title":"Bone"},{"key":"R29-10-20210211","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archinte.167.13.1379","article-title":"Albuminuria and risk of nonvertebral fractures.","volume":"167","author":"Jorgensen","year":"2007","journal-title":"Arch Intern Med"},{"key":"R30-10-20210211","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/j.ajkd.2007.07.014","article-title":"Disease progression and outcomes in type 1 diabetic kidney transplant recipients based on posttransplantation CKD staging.","volume":"50","author":"Smavatkul","year":"2007","journal-title":"Am J Kidney Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200807270-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:59Z","timestamp":1786037999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200807270-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,27]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318176b40f","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7,27]]}}}